Cesca Therapeutics is engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine. We focus in three target markets to serve patients, physicians and partners: •Cellular Therapeutics •Medical/Diagnostic Device Development and Commercialization •Cell Manufacturing and Banking Therapies: Cesca’s lead therapeutic technology platform, SurgWerks® (an intraoperative rapid system for harvesting, selection/purification, testing, and delivering a therapeutic dose of autologous bone marrow derived or peripheral blood derived cells and proteins), is currently in various stages of clinical trials as a potential treatment for acute myocardial infarction, critical limb ischemia, and orthopedic injuries. Medical and Diagnostic Devices: Cesca designs, manufactures and sells advanced devices created specifically for the regenerative medicine bioprocessing market. This market includes biologic collection, transport, processing/washing, characterization/analysis, and cryopreservation. We view the regenerative medicine bioprocessing market as essential to the success of clinical trials through the control of quality of small and large scale cellular manufacturing in three distinct markets (below). Cesca provides an indication-specific device/protocol program called “Cell Werks™” for select applications in the following three markets: •Umbilical Cord Blood Banking •Bone Marrow Transplantation •RegenMed Bio-Process (Clinical/Commercialization Stage Regen Med Companies)
View Top Employees from Cesca Therapeutics Inc.Website | https://www.cescatherapeutics.com |
Ticker | KOOL |
Revenue | $14.5 million |
Funding | $11.3 million |
Employees | 18 (12 on RocketReach) |
Founded | 1986 |
Address | 2711 Citrus Rd, Rancho Cordova, California 95742, US |
Phone | (916) 858-5100 |
Fax | (916) 858-5199 |
Technologies |
JavaScript,
HTML,
PHP
+36 more
(view full list)
|
Industry | Biotechnology, Health Care, Bio-Medical, Medical Devices, Pharmaceuticals, Medical, Medical Device Development, Healthcare, Therapeutics, Cellular Therapies, Cell Manufacturing and Banking |
Web Rank | 6 Million |
Keywords | Cesca Therapeutics, Thermogenesis, Cesca Therapeutics Investor Presentation, Cbr Uses Sepax?, Bioarchive Cesca |
Competitors | Alliqua BioMedical, Inc., Histogenics Corporation, Lisata Therapeutics, Inc., Stryker Orthopedics |
SIC | SIC Code 38 Companies, SIC Code 382 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Cesca Therapeutics Inc. employee's phone or email?
The Cesca Therapeutics Inc. annual revenue was $14.5 million in 2023.
Alfonso Gutierrez is the Director of Information Technology of Cesca Therapeutics Inc..
12 people are employed at Cesca Therapeutics Inc..
Cesca Therapeutics Inc. is based in Rancho Cordova, California.
The NAICS codes for Cesca Therapeutics Inc. are [33, 339, 3254, 32, 325].
The SIC codes for Cesca Therapeutics Inc. are [38, 382].